Older Americans on a Medicare Advantage plan could face hospital bills of $1,000 or more if private insurers start charging out-of-pocket costs for lifesaving COVID-19 care, a new study warns. Cost data show that Medicare Advantage patients pay an average $987 out-of-pocket when they are hospitalized with the seasonal flu, and about 3% pay more… read on > read on >
Putting the oldest people near the front of the line for COVID-19 shots will save more lives and may extend their lifespan, too, researchers say. The new study findings challenge the view that older people should be lower on the list for shots because they have a shorter life expectancy, according to the team from… read on > read on >
While many Americans await their turn for the COVID vaccine, a potentially record-setting number have already had their flu shot. That’s the key finding in a nationwide poll of more conducted in December by the University of Georgia, involving more than 1,000 adults . In all, 43.5% of respondents said they had already had a… read on > read on >
That swollen lymph node under your arm could be a temporary side effect of a COVID-19 shot and not a sign of serious health problems. Radiologists from Massachusetts General Hospital noticed an increase in patients with swollen underarm lymph nodes as they were doing routine mammogram screenings. So they established an approach to help prevent… read on > read on >
It’s already known that green space offers significant benefits in institutional settings, such as hospitals and schools, but new research suggests it may also reduce violence in prisons. In the new study, researchers compared the amount of trees, lawns and shrubs at prisons in England and Wales with data on violence between prisoners, prisoner assaults… read on > read on >
The U.S. Food and Drug Administration on Saturday approved Johnson & Johnson’s single-shot coronavirus vaccine for emergency use after its advisory panel unanimously backed the vaccine a day earlier. Adding a third vaccine to the country’s arsenal will help boost the nation’s limited supply of the two authorized shots, from Pfizer and Moderna. The first… read on > read on >
The U.S. Food and Drug Administration said Friday that it will move quickly to approve Johnson & Johnson’s single-shot coronavirus vaccine for emergency use after its advisory panel unanimously backed the vaccine earlier in the day. In a statement, the agency said it has notified the company and federal officials involved in vaccine distribution so… read on > read on >
In the early weeks of the U.S. vaccine rollout, race looked like it would determine who was willing to get a shot in the arm, but education level now plays the most powerful role in that decision, new research shows. More than three-quarters of adults with at least a bachelor’s degree have been vaccinated or… read on > read on >
Israel is among the first nations in the world to have a majority of its citizens vaccinated against the new coronavirus. That effort may be already paying off, with rates of severe COVID-19 cases declining by two-thirds among Israelis over the age of 69, a new report finds. “These findings provide preliminary evidence of the… read on > read on >
An advisory panel for the U.S. Food and Drug Administration will spend Friday weighing whether a coronavirus vaccine made by Johnson & Johnson should be approved for emergency use. The expert panel is expected to endorse the vaccine, meaning that the United States could have a third vaccine at its disposal as early as Saturday,… read on > read on >
